Contact Us   |   Sign In   |   Join CAHR
Wednesday, October 18, 2017
Share |

 


 

Exploring Canada’s Early Scientific Advice Services with CADTH and Health Canada

 

The Canadian Association for Healthcare Reimbursement (CAHR) is pleased to share its educational webinar regarding regulatory evaluations and health technology assessments at the forefront in providing innovative pharmaceutical manufacturers with early scientific advice.

 

 Exploring Canada’s Early Scientific Advice Services w/CADTH and Health Canada
October 18, 2017 - CLICK HERE for a copy of the PPTX


 

 

Program:

Health Canada and the Canadian Agency for Drugs and Technologies in Health (CADTH) have evolving early advice initiatives. Both organizations are increasing collaboration and working on developing parallel processes with the goal of influencing the generation of complete and relevant evidence early in the drug development plan to meet the needs of both the Canadian regulator and health technology assessment perspectives.

 

The webinar will give participants a close up view of how the processes work, and how to engage with Health Canada and CADTH to ensure they are meeting the needs of manufacturers and health systems.

 

Moderated by Bill Dempster, CEO of 3Sixty Public Affairs, and will include:

  • Lindsay Blaney, Senior Advisor to the Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada

  • Amy Sood, Scientific Advisor and Lead, Scientific Advice Program, Canadian Agency for Drugs and Technologies in Health

  • Don Husereau, Health Policy and Technology Assessment Consultant, with experience in evaluating early advice programs in Canada and globally
 


Membership Software Powered by YourMembership  ::  Legal